Literature DB >> 22573429

Effects of potato-derived protease inhibitors on perianal dermatitis after colon resection for long-segment Hirschsprung's disease.

Steffen Berger1, Janine Rufener, Peter Klimek, Zacharias Zachariou, Colette Boillat.   

Abstract

BACKGROUND: After resection of long-segment Hirschsprung's disease, severe perianal dermatitis (SPAD) may occur because of high stool frequency and elevated concentrations of fecal pancreatic proteases. We investigated prospectively the effect of potato-derived protease inhibitors (PPI) on skin conditions in children with postoperative SPAD.
METHODS: Four children (aged 12 to 24 months) with therapy-resistant SPAD after transanal endorectal pull-through for long-segment Hirschsprung's disease received topical PPI (1% in 20% zinc ointment) with each diaper-change. Parents noted down a subjective dermatitis score daily. Photo documentation and outpatient visits were made to assess the treatment results.
RESULTS: No adverse effects were observed after treatment with PPI. A remarkable improvement of the dermatitis in 3 of the 4 patients as well as improvements in pain and sleep disorders were observed during the PPI-treatment course.
CONCLUSION: The results of the study suggest that PPI may reduce otherwise intractable protease-induced skin irritation in infants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573429     DOI: 10.1007/s12519-012-0356-2

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  16 in total

Review 1.  Anogenital and buttock ulceration in infancy.

Authors:  Anne R Halbert; Jonathan J Chan
Journal:  Australas J Dermatol       Date:  2002-02       Impact factor: 2.875

Review 2.  A review of the pathophysiology, prevention and treatment of irritant diaper dermatitis.

Authors:  David J Atherton
Journal:  Curr Med Res Opin       Date:  2004-05       Impact factor: 2.580

3.  Significance of microflora in proteolysis in the colon.

Authors:  S A Gibson; C McFarlan; S Hay; G T MacFarlane
Journal:  Appl Environ Microbiol       Date:  1989-03       Impact factor: 4.792

4.  Total colonic Hirschsprung's disease: a 28-year experience.

Authors:  Barbara E Wildhaber; Daniel H Teitelbaum; Arnold G Coran
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

5.  Jacquet erosive diaper dermatitis after surgery for Hirschsprung disease.

Authors:  J Rodriguez-Poblador; U González-Castro; S Herranz-Martínez; J Luelmo-Aguilar
Journal:  Pediatr Dermatol       Date:  1998 Jan-Feb       Impact factor: 1.588

6.  Fate of pancreatic enzymes during small intestinal aboral transit in humans.

Authors:  P Layer; V L Go; E P DiMagno
Journal:  Am J Physiol       Date:  1986-10

7.  One-stage Soave pull-through for Hirschsprung's disease: a comparison of the transanal and open approaches.

Authors:  J C Langer; M Seifert; R K Minkes
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

8.  Perianal pseudoverrucous papules and nodules after surgery for Hirschsprung disease.

Authors:  L Rodríguez Cano; V García-Patos Briones; R Pedragosa Jové; A Castells Rodellas
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

9.  One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience with 141 children.

Authors:  Jacob C Langer; Audrey C Durrant; Luis de la Torre; Daniel H Teitelbaum; Robert K Minkes; Michael G Caty; Barbara E Wildhaber; S Jose Ortega; Shinjiro Hirose; Craig T Albanese
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

Review 10.  Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease.

Authors:  P Layer; J Keller
Journal:  J Clin Gastroenterol       Date:  1999-01       Impact factor: 3.062

View more
  3 in total

Review 1.  Identifying Information Needs for Hirschsprung Disease Through Caregiver Involvement via Social Media: A Prioritization Study and Literature Review.

Authors:  Kristy Dm Wittmeier; Kendall Hobbs-Murison; Cindy Holland; Elizabeth Crawford; Hal Loewen; Melanie Morris; Suyin Lum Min; Ahmed Abou-Setta; Richard Keijzer
Journal:  J Med Internet Res       Date:  2018-12-21       Impact factor: 5.428

2.  Characterization of Serine Protease Inhibitor from Solanum tuberosum Conjugated to Soluble Dextran and Particle Carriers.

Authors:  Erika Billinger; Shusheng Zuo; Gunnar Johansson
Journal:  ACS Omega       Date:  2019-10-25

Review 3.  Cutting edge technologies in chronic inflammation research.

Authors:  Jon D Laman
Journal:  Exp Dermatol       Date:  2022-09       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.